{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T19:04:26Z","timestamp":1792177466797,"version":"4.4.0"},"reference-count":66,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"the European Community"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Autoimmunity"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1016\/j.jaut.2013.12.015","type":"journal-article","created":{"date-parts":[[2014,1,7]],"date-time":"2014-01-07T02:15:28Z","timestamp":1389060928000},"page":"53-63","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":139,"special_numbering":"C","title":["Both Treg cells and Tconv cells are defective in the Myasthenia gravis thymus: Roles of IL-17 and TNF-\u03b1"],"prefix":"10.1016","volume":"52","author":[{"given":"Angeline","family":"Gradolatto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dani","family":"Nazzal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9rique","family":"Truffault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacky","family":"Bismuth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elie","family":"Fadel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Foti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Berrih-Aknin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaut.2013.12.015_bib1","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/S0140-6736(75)92779-8","article-title":"Humoral antibodies to acetylcholine receptor in patients with myasthenia gravis","volume":"2","author":"Aharonov","year":"1975","journal-title":"Lancet"},{"key":"10.1016\/j.jaut.2013.12.015_bib2","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1212\/WNL.26.11.1054","article-title":"Antibody to acetylcholine receptor in myasthenia gravis. Prevalence, clinical correlates, and diagnostic value","volume":"26","author":"Lindstrom","year":"1976","journal-title":"Neurology"},{"key":"10.1016\/j.jaut.2013.12.015_bib3","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.autrev.2013.03.011","article-title":"Ectopic germinal centers, BAFF and anti-B-cell therapy in myasthenia gravis","volume":"12","author":"Berrih-Aknin","year":"2013","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.jaut.2013.12.015_bib4","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/S0003-4975(10)66861-0","article-title":"Thymectomy for myasthenia gravis: recent observations and comparisons with past experience","volume":"48","author":"Mulder","year":"1989","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.jaut.2013.12.015_bib5","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/1010-7940(90)90233-P","article-title":"Myasthenia gravis: effect of thymectomy in 425 patients. A 15-year experience","volume":"4","author":"Molnar","year":"1990","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.jaut.2013.12.015_bib6","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1172\/JCI115843","article-title":"Transplantation of thymic autoimmune microenvironment to severe combined immunodeficiency mice. A new model of myasthenia gravis","volume":"90","author":"Schonbeck","year":"1992","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jaut.2013.12.015_bib7","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1002\/1531-8249(199910)46:4<559::AID-ANA3>3.0.CO;2-S","article-title":"Prevention of autoimmune attack by targeting specific T-cell receptors in a severe combined immunodeficiency mouse model of myasthenia gravis","volume":"46","author":"Aissaoui","year":"1999","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jaut.2013.12.015_bib8","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/j.0105-2896.2006.00417.x","article-title":"Human regulatory T cells and their role in autoimmune disease","volume":"212","author":"Baecher-Allan","year":"2006","journal-title":"Immunol Rev"},{"key":"10.1016\/j.jaut.2013.12.015_bib9","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.4049\/jimmunol.155.3.1151","article-title":"Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases","volume":"155","author":"Sakaguchi","year":"1995","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jaut.2013.12.015_bib10","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1084\/jem.184.6.2393","article-title":"The thymus contains a high frequency of cells that prevent autoimmune diabetes on transfer into prediabetic recipients","volume":"184","author":"Saoudi","year":"1996","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.jaut.2013.12.015_bib11","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.autrev.2011.09.008","article-title":"Regulatory T cells in systemic lupus erythematosus (SLE); role of peptide tolerance","volume":"11","author":"Sawla","year":"2012","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.jaut.2013.12.015_bib12","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1007\/s10875-008-9236-x","article-title":"Multiple sclerosis and regulatory T cells","volume":"28","author":"Costantino","year":"2008","journal-title":"J\u00a0Clin Immunol"},{"key":"10.1016\/j.jaut.2013.12.015_bib13","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1182\/blood-2003-11-3900","article-title":"Functional defect of regulatory CD4(+)CD25+ T cells in the thymus of patients with autoimmune myasthenia gravis","volume":"105","author":"Balandina","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.jaut.2013.12.015_bib14","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1212\/WNL.0b013e3181d31e47","article-title":"Undiminished regulatory T cells in the thymus of patients with myasthenia gravis","volume":"74","author":"Matsui","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.jaut.2013.12.015_bib15","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/j.1365-2567.2005.02220.x","article-title":"Circulating and thymic CD4 CD25 T regulatory cells in myasthenia gravis: effect of immunosuppressive treatment","volume":"116","author":"Fattorossi","year":"2005","journal-title":"Immunology"},{"key":"10.1016\/j.jaut.2013.12.015_bib16","first-page":"54","article-title":"Circulating CD4+CD25+ T regulatory and natural killer T cells in patients with myasthenia gravis: a flow cytometry study","volume":"19","author":"Battaglia","year":"2005","journal-title":"J\u00a0Biol Regul Homeost Agents"},{"key":"10.1016\/j.jaut.2013.12.015_bib17","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.imlet.2008.11.015","article-title":"The role of FoxP3+CD4+CD25hi Tregs in the pathogenesis of myasthenia gravis","volume":"122","author":"Zhang","year":"2009","journal-title":"Immunol Lett"},{"key":"10.1016\/j.jaut.2013.12.015_bib18","doi-asserted-by":"crossref","first-page":"841","DOI":"10.4049\/jimmunol.0802046","article-title":"Prednisolone treatment induces tolerogenic dendritic cells and a regulatory milieu in myasthenia gravis patients","volume":"183","author":"Luther","year":"2009","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jaut.2013.12.015_bib19","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.clim.2012.09.012","article-title":"Impaired regulatory function in circulating CD4(+)CD25(high)CD127(low\/-) T cells in patients with myasthenia gravis","volume":"145","author":"Thiruppathi","year":"2012","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jaut.2013.12.015_bib20","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1111\/j.1365-2249.2008.03810.x","article-title":"Increased resistance to CD4+CD25hi regulatory T cell-mediated suppression in patients with type 1 diabetes","volume":"154","author":"Lawson","year":"2008","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jaut.2013.12.015_bib21","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1002\/art.23556","article-title":"Reduced CD4+,CD25\u2212 T cell sensitivity to the suppressive function of CD4+,CD25high,CD127\u2212\/low regulatory T cells in patients with active systemic lupus erythematosus","volume":"58","author":"Venigalla","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaut.2013.12.015_bib22","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.2337\/diabetes.54.5.1415","article-title":"Autoimmune diabetes onset results from qualitative rather than quantitative age-dependent changes in pathogenic T-cells","volume":"54","author":"You","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.jaut.2013.12.015_bib23","doi-asserted-by":"crossref","first-page":"310","DOI":"10.3109\/08916934.2012.664667","article-title":"Downregulation of TGF-betaRII in T effector cells leads to increased resistance to TGF-beta-mediated suppression of autoimmune responses in type I diabetes","volume":"45","author":"Kawamoto","year":"2012","journal-title":"Autoimmunity"},{"key":"10.1016\/j.jaut.2013.12.015_bib24","doi-asserted-by":"crossref","first-page":"7350","DOI":"10.4049\/jimmunol.181.10.7350","article-title":"The effector T cells of diabetic subjects are resistant to regulation via CD4+ FOXP3+ regulatory T cells","volume":"181","author":"Schneider","year":"2008","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jaut.2013.12.015_bib25","doi-asserted-by":"crossref","first-page":"3730","DOI":"10.1002\/art.24048","article-title":"Increased number and function of FoxP3 regulatory T cells during experimental arthritis","volume":"58","author":"Monte","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaut.2013.12.015_bib26","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1002\/art.20976","article-title":"MRL\/Mp CD4+,CD25- T cells show reduced sensitivity to suppression by CD4+,CD25+ regulatory T cells in\u00a0vitro: a novel defect of T cell regulation in systemic lupus erythematosus","volume":"52","author":"Monk","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaut.2013.12.015_bib27","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.it.2007.02.003","article-title":"'Vive la Resistance!'\u2013the PI3K-Akt pathway can determine target sensitivity to regulatory T cell suppression","volume":"28","author":"Wohlfert","year":"2007","journal-title":"Trends Immunol"},{"key":"10.1016\/j.jaut.2013.12.015_bib28","doi-asserted-by":"crossref","first-page":"2480","DOI":"10.1002\/eji.200425274","article-title":"Interleukin-2 is essential for CD4+CD25+ regulatory T cell function","volume":"34","author":"de la Rosa","year":"2004","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jaut.2013.12.015_bib29","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.cytogfr.2009.02.002","article-title":"Interleukin-21 (IL-21)-mediated pathways in T cell-mediated disease","volume":"20","author":"Monteleone","year":"2009","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.jaut.2013.12.015_bib30","doi-asserted-by":"crossref","first-page":"732","DOI":"10.4049\/jimmunol.178.2.732","article-title":"IL-21 counteracts the regulatory T cell-mediated suppression of human CD4+ T lymphocytes","volume":"178","author":"Peluso","year":"2007","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jaut.2013.12.015_bib31","doi-asserted-by":"crossref","first-page":"3538","DOI":"10.1182\/blood-2010-12-328187","article-title":"Functional human regulatory T cells fail to control autoimmune inflammation due to PKB\/c-akt hyperactivation in effector cells","volume":"118","author":"Wehrens","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.jaut.2013.12.015_bib32","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1111\/j.1365-2567.2009.03053.x","article-title":"Regulatory T cells overturned: the effectors fight back","volume":"126","author":"Walker","year":"2009","journal-title":"Immunology"},{"key":"10.1016\/j.jaut.2013.12.015_bib33","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/nrrheum.2012.149","article-title":"T\u00a0cells out of control\u2013impaired immune regulation in the inflamed joint","volume":"9","author":"Wehrens","year":"2013","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.jaut.2013.12.015_bib34","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/nm1564","article-title":"Myelin-specific regulatory T cells accumulate in the CNS but fail to control autoimmune inflammation","volume":"13","author":"Korn","year":"2007","journal-title":"Nat Med"},{"key":"10.1016\/j.jaut.2013.12.015_bib35","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.cellimm.2012.09.001","article-title":"Anti-TNF-alpha therapy improves Treg and suppresses Teff in patients with rheumatoid arthritis","volume":"279","author":"Huang","year":"2012","journal-title":"Cell Immunol"},{"key":"10.1016\/j.jaut.2013.12.015_bib36","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1038\/nm.3085","article-title":"Phosphorylation of FOXP3 controls regulatory T cell function and is inhibited by TNF-alpha in rheumatoid arthritis","volume":"19","author":"Nie","year":"2013","journal-title":"Nat Med"},{"key":"10.1016\/j.jaut.2013.12.015_bib37","doi-asserted-by":"crossref","first-page":"3287","DOI":"10.1182\/blood.V89.9.3287","article-title":"Thymocyte Fas expression is dysregulated in myasthenia gravis patients with anti-acetylcholine receptor antibody","volume":"89","author":"Moulian","year":"1997","journal-title":"Blood"},{"issue":"Suppl.\u00a01","key":"10.1016\/j.jaut.2013.12.015_bib38","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1186\/1471-2105-8-S1-S21","article-title":"The genopolis microarray database","volume":"8","author":"Splendiani","year":"2007","journal-title":"BMC Bioinformatics"},{"key":"10.1016\/j.jaut.2013.12.015_bib39","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1172\/JCI19441","article-title":"Induction of FoxP3 and acquisition of T regulatory activity by stimulated human CD4+CD25\u2212 T cells","volume":"112","author":"Walker","year":"2003","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jaut.2013.12.015_bib40","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1186\/1471-2105-7-335","article-title":"AMDA: an R package for the automated microarray data analysis","volume":"7","author":"Pelizzola","year":"2006","journal-title":"BMC Bioinformatics"},{"key":"10.1016\/j.jaut.2013.12.015_bib41","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.febslet.2004.07.055","article-title":"Rank products: a simple, yet powerful, new method to detect differentially regulated genes in replicated microarray experiments","volume":"573","author":"Breitling","year":"2004","journal-title":"FEBS Lett"},{"key":"10.1016\/j.jaut.2013.12.015_bib42","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.jaci.2010.11.050","article-title":"Interleukins, from 1 to 37, and interferon-gamma: receptors, functions, and roles in diseases","volume":"127","author":"Akdis","year":"2011","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaut.2013.12.015_bib43","doi-asserted-by":"crossref","first-page":"401","DOI":"10.3109\/08916930903563491","article-title":"Thymic remodeling associated with hyperplasia in myasthenia gravis","volume":"43","author":"Le Panse","year":"2010","journal-title":"Autoimmunity"},{"key":"10.1016\/j.jaut.2013.12.015_bib44","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1749-6632.1987.tb51282.x","article-title":"The role of the thymus in myasthenia gravis: immunohistological and immunological studies in 115 cases","volume":"505","author":"Berrih-Aknin","year":"1987","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.jaut.2013.12.015_bib45","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/j.autrev.2013.03.009","article-title":"Impairment of regulatory T cells in myasthenia gravis: studies in an experimental model","volume":"12","author":"Gertel-Lapter","year":"2013","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.jaut.2013.12.015_bib46","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1002\/art.22414","article-title":"Proinflammatory mediator-induced reversal of CD4+,CD25+ regulatory T cell-mediated suppression in rheumatoid arthritis","volume":"56","author":"van Amelsfort","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaut.2013.12.015_bib47","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.immuni.2008.05.007","article-title":"Molecular antagonism and plasticity of regulatory and inflammatory T cell programs","volume":"29","author":"Yang","year":"2008","journal-title":"Immunity"},{"key":"10.1016\/j.jaut.2013.12.015_bib48","first-page":"121","article-title":"Interleukin-6 overproduction by cultured thymic epithelial cells from patients with myasthenia gravis is potentially involved in thymic hyperplasia","volume":"4","author":"Cohen-Kaminsky","year":"1993","journal-title":"Eur Cytokine Netw"},{"key":"10.1016\/j.jaut.2013.12.015_bib49","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0165-5728(98)00253-7","article-title":"Tumour necrosis factor-alpha polymorphism and secretion in myasthenia gravis","volume":"94","author":"Huang","year":"1999","journal-title":"J\u00a0Neuroimmunol"},{"key":"10.1016\/j.jaut.2013.12.015_bib50","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/ana.23791","article-title":"Implication of double-stranded RNA signaling in the etiology of autoimmune myasthenia gravis","volume":"73","author":"Cufi","year":"2013","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jaut.2013.12.015_bib51","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/j.jaci.2010.01.016","article-title":"IL-32 is expressed by human primary keratinocytes and modulates keratinocyte apoptosis in atopic dermatitis","volume":"125","author":"Meyer","year":"2010","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"Suppl.\u00a03","key":"10.1016\/j.jaut.2013.12.015_bib52","article-title":"IL-32, a novel cytokine with a possible role in disease","volume":"65","author":"Dinarello","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaut.2013.12.015_bib53","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1128\/cdli.4.1.79-84.1997","article-title":"Novel compound tetra-, dinucleotide microsatellite polymorphism in the tumor necrosis factor\/lymphotoxin locus","volume":"4","author":"Greenberg","year":"1997","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.jaut.2013.12.015_bib54","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0165-5728(93)90055-4","article-title":"Immune activation in myasthenia gravis: soluble interleukin-2 receptor, interferon-gamma and tumor necrosis factor-alpha levels in patients' serum","volume":"48","author":"Confalonieri","year":"1993","journal-title":"J\u00a0Neuroimmunol"},{"key":"10.1016\/j.jaut.2013.12.015_bib55","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0165-5728(96)00152-X","article-title":"Tumor necrosis factor-alpha, lymphotoxin, interleukin (IL)-6, IL-10, IL-12 and perforin mRNA expression in mononuclear cells in response to acetylcholine receptor is augmented in myasthenia gravis","volume":"71","author":"Matusevicius","year":"1996","journal-title":"J\u00a0Neuroimmunol"},{"key":"10.1016\/j.jaut.2013.12.015_bib56","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1056\/NEJMoa1105143","article-title":"Regulatory T-cell responses to low-dose interleukin-2 in HCV-induced vasculitis","volume":"365","author":"Saadoun","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaut.2013.12.015_bib57","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.4049\/jimmunol.145.7.2115","article-title":"Thymic B cells from myasthenia gravis patients are activated B cells. Phenotypic and functional analysis","volume":"145","author":"Leprince","year":"1990","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jaut.2013.12.015_bib58","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S1074-7613(00)80038-2","article-title":"Impaired on\/off regulation of TNF biosynthesis in mice lacking TNF AU-rich elements: implications for joint and gut-associated immunopathologies","volume":"10","author":"Kontoyiannis","year":"1999","journal-title":"Immunity"},{"key":"10.1016\/j.jaut.2013.12.015_bib59","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/S0165-5728(01)00473-8","article-title":"Treatment of experimental autoimmune myasthenia gravis with recombinant human tumor necrosis factor receptor Fc protein","volume":"122","author":"Christadoss","year":"2002","journal-title":"J\u00a0Neuroimmunol"},{"key":"10.1016\/j.jaut.2013.12.015_bib60","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1006\/jaut.2002.0618","article-title":"Anti-TNF-alpha antibodies suppress the development of experimental autoimmune myasthenia gravis","volume":"19","author":"Duan","year":"2002","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.jaut.2013.12.015_bib61","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/j.1600-0404.2006.00778.x","article-title":"A\u00a0clinical and immunological study of a myasthenia gravis patient treated with infliximab","volume":"115","author":"Kakoulidou","year":"2007","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.jaut.2013.12.015_bib62","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.1212\/01.WNL.0000147242.92691.71","article-title":"Etanercept treatment in corticosteroid-dependent myasthenia gravis","volume":"63","author":"Rowin","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.jaut.2013.12.015_bib63","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.jaut.2005.01.013","article-title":"Myasthenia gravis patients with low plasma IL-6 and IFN-gamma benefit from etanercept treatment","volume":"24","author":"Tuzun","year":"2005","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.jaut.2013.12.015_bib64","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1002\/mus.21280","article-title":"Myasthenia gravis associated with etanercept therapy","volume":"39","author":"Fee","year":"2009","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jaut.2013.12.015_bib65","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.autrev.2011.01.005","article-title":"Mesenchymal stem cells as an immunomodulatory therapeutic strategy for autoimmune diseases","volume":"10","author":"Ben-Ami","year":"2011","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.jaut.2013.12.015_bib66","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.autrev.2013.09.007","article-title":"T\u00a0cells from autoimmune patients display reduced sensitivity to immunoregulation by mesenchymal stem cells: role of IL-2","volume":"13","author":"Ben-Ami","year":"2014","journal-title":"Autoimmun Rev"}],"container-title":["Journal of Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841113001625?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841113001625?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T08:08:37Z","timestamp":1760256517000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0896841113001625"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8]]},"references-count":66,"alternative-id":["S0896841113001625"],"URL":"https:\/\/doi.org\/10.1016\/j.jaut.2013.12.015","relation":{},"ISSN":["0896-8411"],"issn-type":[{"value":"0896-8411","type":"print"}],"subject":[],"published":{"date-parts":[[2014,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Both Treg cells and Tconv cells are defective in the Myasthenia gravis thymus: Roles of IL-17 and TNF-\u03b1","name":"articletitle","label":"Article Title"},{"value":"Journal of Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaut.2013.12.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}